Ursamin, Inc. — SEC Form D Filing
Ursamin, Inc. filed an SEC Form D on November 10, 2026, reporting $125K raised in Healthcare Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- November 10, 2026
- Amount reported
- $125K
- Industry
- Healthcare Technology
- Website
- https://ursamin.com/
What the company does
Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Clinics face a capacity gap as an increasing number of patients require ongoing care for multiple chronic conditions beyond routine visits. Outdated tools and staffing models fail to keep pace, causing care to be delayed or missed while care teams are overburdened.
Solution
Ursamin provides clinical operations infrastructure technology that assembles patient records, identifies care needs, and organizes upcoming care steps across conditions and settings without requiring clinics to add staff at the same rate.
Why now
Rising rates of chronic disease coupled with severe clinical staffing shortages are forcing healthcare providers to adopt software that boosts labor productivity rather than hiring additional staff.
Verdict
Investors wrote this initial check because macro staffing shortages made labor productivity software for clinics an urgent pitch, betting that care coordination could be systematically decoupled from headcount. This cleared because the macro labor crisis created an immediate problem narrative, not because Ursamin demonstrated a defensible moat against entrenched electronic health records. The micro-ticket size reflects an exploratory bet on clinical dissatisfaction rather than institutional conviction in software pricing power, defensibility, or enterprise healthcare sales velocity.
Source: SEC EDGAR Form D filing